Skip to main content
Livermore
Livermore
ZHEN

LENZ Therapeutics, Inc.

LENZ
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001815776

No open-market purchases or sales by LENZ Therapeutics, Inc. insiders were filed in the last 90 days; 145 institutions reported holding it in 13F filings for Q2 2026, worth $197.3M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding LENZ Therapeutics, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of LENZ: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders14611450
Shares33.1M12.2K34.7M+1.59M (+4.8%)
Value$303.3M$112.0K$197.3M−$105.9M (−34.9%)

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held LENZ Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to LENZ in Q2 2026
InstitutionSharesValue% of portfolio
Qube Research & Technologies Ltd482,195$2.74M0.00%
Citadel Advisors LLC363,229$2.06M0.00%
Jefferies Financial Group Inc.200,300$1.14M0.01%
Susquehanna Portfolio Strategies, LLC154,053$875.0K0.01%
Occudo Quantitative Strategies LP146,376$831.4K0.04%
Mangrove Partners96,749$549.5K0.04%
Renaissance Technologies LLC70,628$401.2K0.00%
Quadrature Capital Ltd49,132$279.1K0.00%
Bridgeway Capital Management, LLC45,000$255.6K0.00%
Allstate Corp35,272$200.3K0.00%
Atom Investors LP31,826$180.8K0.02%
Cerity Partners LLC20,571$116.8K0.00%
Aigen Investment Management, LP20,055$113.9K0.03%
MML Investors Services, LLC20,043$113.8K0.00%
Susquehanna Fundamental Investments, LLC17,900$101.7K0.00%
Verdad Advisers, LP15,900$90.3K0.09%
Abel Hall, LLC15,876$90.2K0.02%
Lazard Asset Management LLC12,990$73.8K0.00%
Mercer Global Advisors Inc12,289$69.8K0.00%
Mariner, LLC11,642$66.1K0.00%
Federated Hermes, Inc.4,897$27.8K0.00%
CoreCap Advisors, LLC164$9320.00%
Quarry LP48$2730.00%
Transamerica Financial Advisors, Inc.28$1590.00%
JPL Wealth Management, LLC9$520.00%
Clearstead Advisors, LLC1$60.00%
Wealth Enhancement Trust Services, Inc.1$60.00%

Sold out (27)

Institutions that held LENZ Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of LENZ in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Franklin Resources Inc1,100,148$10.1M
Silvercrest Asset Management Group LLC283,206$2.59M
HRT Financial LP145,506$1.33M
Susquehanna International Group, LLP110,304$1.01M
Vivaldi Capital Management, LLC64,052$586.1K
ExodusPoint Capital Management, LP57,577$526.8K
Virtus Investment Advisers, Inc.46,542$425.9K
Knott David M Jr33,732$308.6K
Engineers Gate Manager LP32,243$295.0K
Voleon Capital Management LP29,992$274.4K
TD Asset Management Inc24,610$225.2K
Swiss National Bank21,800$199.5K
State of Wisconsin Investment Board16,220$148.4K
Rinkey Investments15,186$139.0K
Raymond James Financial Inc15,008$137.3K
Janney Montgomery Scott LLC10,814$99.0K
MetLife Investment Management9,787$89.6K
Vanguard Asset Management, Ltd6,103$55.8K
KLP Kapitalforvaltning AS3,100$28.4K
Vanguard Investments Australia, Ltd.2,432$22.3K
Advisory Services Network, LLC175$1.60K
Scarborough Advisors, LLC80$732
Fifth Third Bancorp79$723
MAI Capital Management32$293
US Bancorp16$146
Stone House Investment Management, LLC6$55
Freestone Grove Partners LP2$18

Not filed for Q2 2026 yet (1)

Institutions that held LENZ Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding LENZ in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
CWM, LLC12,240$112.0K